Luka
college student living with epilepsy
Luka is a freshman at San Diego State University, studying Real Estate in the Business College. He had his first seizure at 14, but his epilepsy is now controlled with daily medication. Luka is a new member of the ZBT fraternity, and he also enjoys weightlifting and playing hockey. Luka says he doesn’t let epilepsy define him or stand in the way of his dreams and aspirations.
Phil Haydon, Phd
Sail For Epilepsy President
Phillip Haydon is an internationally recognized neuroscientist with medically controlled post-traumatic epilepsy. Phil has started the nonprofit organization Sail For Epilepsy with a mission to inspire people with epilepsy to take One More Step towards achieving a fuller life, with the necessary safety measures in place. He plans to navigate the oceans of the world to raise funds for a cure, promote awareness of epilepsy, and educate the public.
OUR SAVINGS AND SUPPORT PROGRAM
We want to ensure that people with neurological conditions using our innovative therapies get the support and savings they need to stay on treatment.
OUR PIPELINE
Our pipeline currently includes several investigational product candidates at various stages of development.
OUR TECHNOLOGIES
Neurelis has a proprietary technology portfolio that includes Intravail®, ProTek®, and Hydrogel™ for drug delivery enhancement. These three non-invasive drug delivery and stabilization technologies are applicable to a wide range of molecules, including therapeutic proteins, peptides, and non-peptide large and small molecules. Our technologies offer exceptional potential value in enhancing drug development and clinical performance.
ABOUT NEURELIS
Neurelis is a neuroscience-based company dedicated to enhancing therapeutic benefit and addressing unmet needs in care for people with neurological conditions.
KEEP CURRENT
Get the most up-to-date information about Neurelis and our products.